Neuroendocrine Tumor

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases

Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study

Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET

Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients

Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor

Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study

Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor: a Randomized Pilot Study

DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor

Optimal Feeding for NET Patients

Surgical Intervention and the NETest

Application of Al18F-octreotide PET/CT in Neuroendocrine Tumor

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors